BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ikeda H, Nagashima K, Yanase M, Tomiya T, Arai M, Inoue Y, Tejima K, Nishikawa T, Omata M, Kimura S. Involvement of Rho/Rho kinase pathway in regulation of apoptosis in rat hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol. 2003;285:G880-G886. [PMID: 12829436 DOI: 10.1152/ajpgi.00039.2003] [Cited by in Crossref: 49] [Cited by in F6Publishing: 49] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Fuja TJ, Ostrem EM, Probst-fuja MN, Titze IR. Differential cell adhesion to vocal fold extracellular matrix constituents. Matrix Biology 2006;25:240-51. [DOI: 10.1016/j.matbio.2006.01.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
2 Zhang Y, Gu X, Yuan X. Phenylalanine activates the mitochondria-mediated apoptosis through the RhoA/Rho-associated kinase pathway in cortical neurons: RhoA involved apoptosis by phenylalanine in neurons. European Journal of Neuroscience 2007;25:1341-8. [DOI: 10.1111/j.1460-9568.2007.05404.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 2.4] [Reference Citation Analysis]
3 Barbayianni E, Kaffe E, Aidinis V, Kokotos G. Autotaxin, a secreted lysophospholipase D, as a promising therapeutic target in chronic inflammation and cancer. Progress in Lipid Research 2015;58:76-96. [DOI: 10.1016/j.plipres.2015.02.001] [Cited by in Crossref: 71] [Cited by in F6Publishing: 65] [Article Influence: 11.8] [Reference Citation Analysis]
4 Watanabe N, Ikeda H, Nakamura K, Ohkawa R, Kume Y, Aoki J, Hama K, Okudaira S, Tanaka M, Tomiya T. Both plasma lysophosphatidic acid and serum autotaxin levels are increased in chronic hepatitis C. J Clin Gastroenterol. 2007;41:616-623. [PMID: 17577119 DOI: 10.1097/01.mcg.0000225642.90898.0e] [Cited by in Crossref: 135] [Cited by in F6Publishing: 127] [Article Influence: 9.6] [Reference Citation Analysis]
5 Okimoto S, Kuroda S, Tashiro H, Kobayashi T, Taogoshi T, Matsuo H, Ohdan H. Vitamin A‐coupled liposomal Rho‐kinase inhibitor ameliorates liver fibrosis without systemic adverse effects. Hepatol Res 2019;49:663-75. [DOI: 10.1111/hepr.13317] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
6 Hennenberg M, Trebicka J, Stark C, Kohistani AZ, Heller J, Sauerbruch T. Sorafenib targets dysregulated Rho kinase expression and portal hypertension in rats with secondary biliary cirrhosis. Br J Pharmacol. 2009;157:258-270. [PMID: 19338580 DOI: 10.1111/j.1476-5381.2009.00158.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 4.8] [Reference Citation Analysis]
7 Yang F, Chen GX. Production of extracellular lysophosphatidic acid in the regulation of adipocyte functions and liver fibrosis. World J Gastroenterol 2018; 24(36): 4132-4151 [PMID: 30271079 DOI: 10.3748/wjg.v24.i36.4132] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
8 El-batch M, Ibrahim W, Said S. Effect of histidine on autotaxin activity in experimentally induced liver fibrosis. J Biochem Mol Toxicol 2011;25:143-50. [DOI: 10.1002/jbt.20370] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
9 Frisca F, Crombie DE, Dottori M, Goldshmit Y, Pébay A. Rho/ROCK pathway is essential to the expansion, differentiation, and morphological rearrangements of human neural stem/progenitor cells induced by lysophosphatidic acid. J Lipid Res 2013;54:1192-206. [PMID: 23463731 DOI: 10.1194/jlr.M032284] [Cited by in Crossref: 33] [Cited by in F6Publishing: 12] [Article Influence: 4.1] [Reference Citation Analysis]
10 Pleli T, Martin D, Kronenberger B, Brunner F, Köberle V, Grammatikos G, Farnik H, Martinez Y, Finkelmeier F, Labocha S. Serum autotaxin is a parameter for the severity of liver cirrhosis and overall survival in patients with liver cirrhosis--a prospective cohort study. PLoS One. 2014;9:e103532. [PMID: 25062038 DOI: 10.1371/journal.pone.0103532] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 5.7] [Reference Citation Analysis]
11 Rancoule C, Pradère J, Gonzalez J, Klein J, Valet P, Bascands J, Schanstra JP, Saulnier-blache J. Lysophosphatidic acid-1-receptor targeting agents for fibrosis. Expert Opinion on Investigational Drugs 2011;20:657-67. [DOI: 10.1517/13543784.2011.566864] [Cited by in Crossref: 58] [Cited by in F6Publishing: 52] [Article Influence: 5.8] [Reference Citation Analysis]
12 Rancoule C, Espenel S, Trone JC, Langrand-Escure J, Vallard A, Rehailia-Blanchard A, El Meddeb Hamrouni A, Xia Y, Guy JB, Ben-Mrad M, Magné N. Lysophosphatidic acid (LPA) as a pro-fibrotic and pro-oncogenic factor: a pivotal target to improve the radiotherapy therapeutic index. Oncotarget 2017;8:43543-54. [PMID: 28402936 DOI: 10.18632/oncotarget.16672] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
13 van Beuge MM, Prakash J, Lacombe M, Post E, Reker-Smit C, Beljaars L, Poelstra K. Increased liver uptake and reduced hepatic stellate cell activation with a cell-specific conjugate of the Rho-kinase inhibitor Y27632. Pharm Res. 2011;28:2045-2054. [PMID: 21442374 DOI: 10.1007/s11095-011-0430-9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
14 Pyne NJ, Dubois G, Pyne S. Role of sphingosine 1-phosphate and lysophosphatidic acid in fibrosis. Biochim Biophys Acta 2013;1831:228-38. [PMID: 22801038 DOI: 10.1016/j.bbalip.2012.07.003] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 4.2] [Reference Citation Analysis]
15 Wen J, Lin X, Gao W, Qu B, Zuo Y, Liu R, Yu M. Inhibition of LPA 1 Signaling Impedes Conversion of Human Tenon's Fibroblasts into Myofibroblasts Via Suppressing TGF-β/Smad2/3 Signaling. Journal of Ocular Pharmacology and Therapeutics 2019;35:331-40. [DOI: 10.1089/jop.2018.0120] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Rancoule C, Viaud M, Gres S, Viguerie N, Decaunes P, Bouloumié A, Langin D, Bascands JL, Valet P, Saulnier-Blache JS. Pro-fibrotic activity of lysophosphatidic acid in adipose tissue: in vivo and in vitro evidence. Biochim Biophys Acta 2014;1841:88-96. [PMID: 24120919 DOI: 10.1016/j.bbalip.2013.10.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
17 Ikeda H, Kume Y, Tejima K, Tomiya T, Nishikawa T, Watanabe N, Ohtomo N, Arai M, Arai C, Omata M, Fujiwara K, Yatomi Y. Rho-kinase inhibitor prevents hepatocyte damage in acute liver injury induced by carbon tetrachloride in rats. Am J Physiol Gastrointest Liver Physiol 2007;293:G911-7. [PMID: 17761835 DOI: 10.1152/ajpgi.00210.2007] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
18 He H, Pannequin J, Tantiongco JP, Shulkes A, Baldwin GS. Glycine-extended gastrin stimulates cell proliferation and migration through a Rho- and ROCK-dependent pathway, not a Rac/Cdc42-dependent pathway. Am J Physiol Gastrointest Liver Physiol 2005;289:G478-88. [PMID: 15845872 DOI: 10.1152/ajpgi.00034.2005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
19 De Sarno P, Shestopal SA, Zmijewska AA, Jope RS. Anti-apoptotic effects of muscarinic receptor activation are mediated by Rho kinase. Brain Res 2005;1041:112-5. [PMID: 15804506 DOI: 10.1016/j.brainres.2005.01.081] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
20 Ikeda H, Yatomi Y. Autotaxin in liver fibrosis. Clin Chim Acta. 2012;413:1817-1821. [PMID: 22820036 DOI: 10.1016/j.cca.2012.07.014] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 3.9] [Reference Citation Analysis]
21 Eraky SM, El-Mesery M, El-Karef A, Eissa LA, El-Gayar AM. Silymarin and caffeine combination ameliorates experimentally-induced hepatic fibrosis through down-regulation of LPAR1 expression. Biomed Pharmacother 2018;101:49-57. [PMID: 29477472 DOI: 10.1016/j.biopha.2018.02.064] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
22 Shi J, Wei L. Rho kinase in the regulation of cell death and survival. Arch Immunol Ther Exp (Warsz). 2007;55:61-75. [PMID: 17347801 DOI: 10.1007/s00005-007-0009-7] [Cited by in Crossref: 161] [Cited by in F6Publishing: 160] [Article Influence: 11.5] [Reference Citation Analysis]
23 Liu CA, Wang MJ, Chi CW, Wu CW, Chen JY. Overexpression of rho effector rhotekin confers increased survival in gastric adenocarcinoma. J Biomed Sci 2004;11:661-70. [PMID: 15316142 DOI: 10.1007/BF02256132] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
24 Labandeira-garcia JL, Rodríguez-perez AI, Villar-cheda B, Borrajo A, Dominguez-meijide A, Guerra MJ. Rho Kinase and Dopaminergic Degeneration: A Promising Therapeutic Target for Parkinson’s Disease. Neuroscientist 2015;21:616-29. [DOI: 10.1177/1073858414554954] [Cited by in Crossref: 23] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
25 Uranbileg B, Enooku K, Soroida Y, Ohkawa R, Kudo Y, Nakagawa H, Tateishi R, Yoshida H, Shinzawa S, Moriya K, Ohtomo N, Nishikawa T, Inoue Y, Tomiya T, Kojima S, Matsuura T, Koike K, Yatomi Y, Ikeda H. High ubiquitous mitochondrial creatine kinase expression in hepatocellular carcinoma denotes a poor prognosis with highly malignant potential. Int J Cancer 2014;134:2189-98. [PMID: 24174293 DOI: 10.1002/ijc.28547] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
26 Kageyama Y, Ikeda H, Watanabe N, Nagamine M, Kusumoto Y, Yashiro M, Satoh Y, Shimosawa T, Shinozaki K, Tomiya T, Inoue Y, Nishikawa T, Ohtomo N, Tanoue Y, Yokota H, Koyama T, Ishimaru K, Okamoto Y, Takuwa Y, Koike K, Yatomi Y. Antagonism of sphingosine 1-phosphate receptor 2 causes a selective reduction of portal vein pressure in bile duct-ligated rodents. Hepatology 2012;56:1427-38. [DOI: 10.1002/hep.25780] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 3.6] [Reference Citation Analysis]
27 Tsukada S, Parsons CJ, Rippe RA. Mechanisms of liver fibrosis. Clin Chim Acta. 2006;364:33-60. [PMID: 16139830 DOI: 10.1016/j.cca.2005.06.014] [Cited by in Crossref: 223] [Cited by in F6Publishing: 232] [Article Influence: 13.9] [Reference Citation Analysis]
28 Kong D, Zhang F, Zhang Z, Lu Y, Zheng S. Clearance of activated stellate cells for hepatic fibrosis regression: molecular basis and translational potential. Biomed Pharmacother. 2013;67:246-250. [PMID: 23201010 DOI: 10.1016/j.biopha.2012.10.002] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 3.4] [Reference Citation Analysis]
29 Wei L, Yang J, Wang M, Xu SN, Liang HM, Zhou Q. Sodium ferulate lowers portal pressure in rats with secondary biliary cirrhosis through the RhoA/Rho-kinase signaling pathway: a preliminary study. Int J Mol Med. 2014;34:1257-1267. [PMID: 25174394 DOI: 10.3892/ijmm.2014.1905] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
30 Udomsinprasert W, Vejchapipat P, Klaikeaw N, Chongsrisawat V, Poovorawan Y, Honsawek S. Hepatic autotaxin overexpression in infants with biliary atresia. PeerJ 2018;6:e5224. [PMID: 30065861 DOI: 10.7717/peerj.5224] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
31 Kitamura K, Tada S, Nakamoto N, Toda K, Horikawa H, Kurita S, Tsunematsu S, Kumagai N, Ishii H, Saito H. Rho/Rho kinase is a key enzyme system involved in the angiotensin II signaling pathway of liver fibrosis and steatosis. J Gastroenterol Hepatol. 2007;22:2022-2033. [PMID: 17914985 DOI: 10.1111/j.1440-1746.2006.04735.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 2.3] [Reference Citation Analysis]
32 State-of-the-art conference on azidothymidine therapy for early HIV infection. Am J Med. 1990;89:335-344. [PMID: 2203263 DOI: 10.1111/j.1365-2036.2011.04896.x] [Cited by in Crossref: 60] [Cited by in F6Publishing: 58] [Article Influence: 1.9] [Reference Citation Analysis]
33 Ikeda H, Nagashima K, Yanase M, Tomiya T, Arai M, Inoue Y, Tejima K, Nishikawa T, Watanabe N, Omata M, Fujiwara K. Sphingosine 1-phosphate enhances portal pressure in isolated perfused liver via S1P2 with Rho activation. Biochemical and Biophysical Research Communications 2004;320:754-9. [DOI: 10.1016/j.bbrc.2004.04.207] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 1.5] [Reference Citation Analysis]
34 Wickman GR, Samuel MS, Lochhead PA, Olson MF. The Rho-Regulated ROCK Kinases in Cancer. In: Golen K, editor. The Rho GTPases in Cancer. New York: Springer; 2010. pp. 163-92. [DOI: 10.1007/978-1-4419-1111-7_11] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
35 Galvão I, Athayde RM, Perez DA, Reis AC, Rezende L, de Oliveira VLS, Rezende BM, Gonçalves WA, Sousa LP, Teixeira MM, Pinho V. ROCK Inhibition Drives Resolution of Acute Inflammation by Enhancing Neutrophil Apoptosis. Cells 2019;8:E964. [PMID: 31450835 DOI: 10.3390/cells8090964] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
36 Gerhard R, Nottrott S, Schoentaube J, Tatge H, Olling A, Just I. Glucosylation of Rho GTPases by Clostridium difficile toxin A triggers apoptosis in intestinal epithelial cells. Journal of Medical Microbiology 2008;57:765-70. [DOI: 10.1099/jmm.0.47769-0] [Cited by in Crossref: 76] [Cited by in F6Publishing: 67] [Article Influence: 5.8] [Reference Citation Analysis]
37 Elsharkawy AM, Oakley F, Mann DA. The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis. Apoptosis. 2005;10:927-939. [PMID: 16151628 DOI: 10.1007/s10495-005-1055-4] [Cited by in Crossref: 294] [Cited by in F6Publishing: 288] [Article Influence: 19.6] [Reference Citation Analysis]
38 Sterpetti P, Marucci L, Candelaresi C, Toksoz D, Alpini G, Ugili L, Baroni GS, Macarri G, Benedetti A. Cell proliferation and drug resistance in hepatocellular carcinoma are modulated by Rho GTPase signals. Am J Physiol Gastrointest Liver Physiol 2006;290:G624-32. [PMID: 16322093 DOI: 10.1152/ajpgi.00128.2005] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.5] [Reference Citation Analysis]
39 Watanabe N, Ikeda H, Nakamura K, Ohkawa R, Kume Y, Tomiya T, Tejima K, Nishikawa T, Arai M, Yanase M. Plasma lysophosphatidic acid level and serum autotaxin activity are increased in liver injury in rats in relation to its severity. Life Sci. 2007;81:1009-1015. [PMID: 17850827 DOI: 10.1016/j.lfs.2007.08.013] [Cited by in Crossref: 74] [Cited by in F6Publishing: 76] [Article Influence: 5.3] [Reference Citation Analysis]
40 Melton AC, Datta A, Yee HF. [Ca2+]i-independent contractile force generation by rat hepatic stellate cells in response to endothelin-1. Am J Physiol Gastrointest Liver Physiol. 2006;290:G7-13. [PMID: 16123199 DOI: 10.1152/ajpgi.00337.2005] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 2.0] [Reference Citation Analysis]
41 Udomsinprasert W, Kitkumthorn N, Mutirangura A, Chongsrisawat V, Poovorawan Y, Honsawek S. Association between Promoter Hypomethylation and Overexpression of Autotaxin with Outcome Parameters in Biliary Atresia. PLoS One 2017;12:e0169306. [PMID: 28052132 DOI: 10.1371/journal.pone.0169306] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
42 Takata A, Otsuka M, Kishikawa T, Yamagami M, Ishibashi R, Sekiba K, Suzuki T, Ohno M, Yamashita Y, Abe T, Masuzaki R, Ikenoue T, Koike K. RASAL1 is a potent regulator of hepatic stellate cell activity and liver fibrosis. Oncotarget 2017;8:64840-52. [PMID: 29029395 DOI: 10.18632/oncotarget.17609] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
43 von Elsner L, Hagemann S, Just I, Rohrbeck A. C3 exoenzyme impairs cell proliferation and apoptosis by altering the activity of transcription factors. Naunyn Schmiedebergs Arch Pharmacol. 2016;389:1021-1031. [PMID: 27351882 DOI: 10.1007/s00210-016-1270-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
44 Rodriguez-Pallares J, Rodriguez-Perez AI, Muñoz A, Parga JA, Toledo-Aral JJ, Labandeira-Garcia JL. Effects of Rho Kinase Inhibitors on Grafts of Dopaminergic Cell Precursors in a Rat Model of Parkinson's Disease. Stem Cells Transl Med 2016;5:804-15. [PMID: 27075764 DOI: 10.5966/sctm.2015-0182] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
45 Ma J, Liang S, Wang Z, Zhang L, Jiang J, Zheng J, Yu L, Zheng X, Wang R, Zhu D. ROCK pathway participates in the processes that 15-hydroxyeicosatetraenoic acid (15-HETE) mediated the pulmonary vascular remodeling induced by hypoxia in rat. J Cell Physiol 2010;222:82-94. [PMID: 19746421 DOI: 10.1002/jcp.21923] [Cited by in Crossref: 61] [Cited by in F6Publishing: 61] [Article Influence: 5.1] [Reference Citation Analysis]
46 Wu Y, Shu J, He C, Li M, Wang Y, Ou W, He Y. ROCK inhibitor Y27632 promotes proliferation and diminishes apoptosis of marmoset induced pluripotent stem cells by suppressing expression and activity of caspase 3. Theriogenology 2016;85:302-14. [PMID: 26476594 DOI: 10.1016/j.theriogenology.2015.09.020] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
47 Yao L, Yao ZM, Weng H, Zhao GP, Zhou YJ, Yu T. Effect of rat serum containing Biejiajian oral liquid on proliferation of rat hepatic stellate cells. World J Gastroenterol 2004; 10(13): 1911-1913 [PMID: 15222035 DOI: 10.3748/wjg.v10.i13.1911] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
48 Yao XX, Jiang SL, Tang YW, Yao DM, Yao X. Efficacy of Chinese medicine Yi-gan-kang granule in prophylaxis and treatment of liver fibrosis in rats. World J Gastroenterol 2005; 11(17): 2583-2590 [PMID: 15849816 DOI: 10.3748/wjg.v11.i17.2583] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]